Cargando…
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8(+) T cell tumor-infiltration impairing anti-PD1 therapy
Cancer response to immunotherapy depends on the infiltration of CD8(+) T cells and the presence of tumor-associated macrophages within tumors. Still, little is known about the determinants of these factors. We show that LIF assumes a crucial role in the regulation of CD8(+) T cell tumor infiltration...
Autores principales: | Pascual-García, Mónica, Bonfill-Teixidor, Ester, Planas-Rigol, Ester, Rubio-Perez, Carlota, Iurlaro, Raffaella, Arias, Alexandra, Cuartas, Isabel, Sala-Hojman, Ada, Escudero, Laura, Martínez-Ricarte, Francisco, Huber-Ruano, Isabel, Nuciforo, Paolo, Pedrosa, Leire, Marques, Carolina, Braña, Irene, Garralda, Elena, Vieito, María, Squatrito, Massimo, Pineda, Estela, Graus, Francesc, Espejo, Carmen, Sahuquillo, Juan, Tabernero, Josep, Seoane, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559950/ https://www.ncbi.nlm.nih.gov/pubmed/31186412 http://dx.doi.org/10.1038/s41467-019-10369-9 |
Ejemplares similares
-
Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment
por: Rubio-Perez, Carlota, et al.
Publicado: (2021) -
Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide
por: Bonfill-Teixidor, Ester, et al.
Publicado: (2017) -
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
por: Borazanci, E., et al.
Publicado: (2022) -
New clinical trial designs in the era of precision medicine
por: Garralda, Elena, et al.
Publicado: (2019) -
Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF
por: Metcalfe, Su M., et al.
Publicado: (2015)